Cargando…
Constructing narratives of heroism and villainy: case study of Myriad's BRACAnalysis(® )compared to Genentech's Herceptin(®)
BACKGROUND: The development of Herceptin(® )is welcomed as a major advance in breast cancer treatment, while Myriad's development of BRACAnalysis(® )is a widely used diagnostic. However useful and successful this product is, its presence in the public eye is tainted by predominantly negative pr...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3707051/ https://www.ncbi.nlm.nih.gov/pubmed/23369278 http://dx.doi.org/10.1186/gm412 |